The pharma company gave several presentations at AAIC 2026 on trontinemab’s potential role in Alzheimer’s as the drug ...

The Hanover Insurance Group, Inc., (NYSE: THG), a leading property and casualty insurance company, announced today that John ...

The Hanover Insurance Group chief operating officer Richard W. Lavey will become the company's next CEO when John C. Roche ...

The Hanover Insurance Group named Richard W. Lavey as chief executive-elect after CEO John "Jack" C. Roche announced plans to retire Dec. 31. Currently chief operating officer of Hanover Agency ...

Roche Holding shares have delivered a 35.0% return over the past three years, and the stock now screens as undervalued on ...

These two programme terminations leave Roche with just one Huntington’s disease candidate.

The Hanover Insurance Group, Inc., (NYSE: THG), a leading property and casualty insurance company, announced today that John "Jack" C. Roche ...

Roche’s biggest bet in the Alzheimer’s disease space may be its phase 3-stage amyloid asset, but the Swiss pharma is keeping its options open when it comes to targeting tau. Tau is one of two proteins ...

The 170-acre northeast-side Indianapolis campus is composed of 21 buildings and serves as one of the company’s two global hubs.

Dena Roché talks wine writing, travel journalism, and building a career that blends storytelling with corporate wine events ...

Following an independent salary analysis, this landmark certification sets a benchmark for data-driven pay equity and ...

US FDA grants Priority Review to Roche’s Gazyva/Gazyvaro for adults with primary membranous nephropathy: Basel Thursday, July 16, 2026, 09:00 Hrs [IST] Roche announced that the ...